Bioequivalence Study of Two Formulations of Atorvastatin Film-coated Tablets 40 mg in Healthy Volunteers Under Fasting Conditions
Clinical trial NCT05642845 · COMPLETED
Trial details
- NCT number
- NCT05642845
- Sponsor
- Pharmtechnology LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-19
- Primary completion
- 2022-12-21
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.